ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CVRX vs DRIO // PIOTROSKI F-SCORE QUALITY

CVRx Inc. (NASDAQ) VS. DarioHealth Corp. (NASDAQ) • 15-METRIC TALLY: CVRX 3 — DRIO 0
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CVRX VS. DRIO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CVRX DRIO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 85.30% 56.60% +28.70 CVRX /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 10.40% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 5/9 5/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 33.4 29.8 +3.60 CVRX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $38.0M $32.4M $5.5M CVRX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CVRX REV DRIO REV CVRX GROSS % DRIO GROSS % CVRX FCF DRIO FCF
FY 2025 $56.7M $22.4M 85.3% 56.6% -$40.8M -$26.1M
FY 2024 $51.3M $27.0M 83.8% 49.1% -$40.5M -$38.7M
FY 2023 $39.3M $0 — — -$39.0M -$30.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CVRX // BETA —
DRIO // BETA —